Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-02-14 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion +12,500 25,080
2013-02-14 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion +4,687 29,767
2013-02-14 Kelly James Patrick SVP, CFO, Sec & Treasurer Shares withheld for taxes −6,978 $3.95 $28K 22,789
2013-02-14 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −12,500 25,000
2013-02-14 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −4,687 14,063
2012-12-07 Repella Robert SVP & Cheif Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +56,250 56,250
2012-12-07 Repella Robert SVP & Cheif Commercial Officer Grant or award · Restricted Stock Unit +18,750 18,750
2012-12-07 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Employee Stock Option (Right to Buy) +56,250 56,250
2012-12-07 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Restricted Stock Unit +18,750 18,750
2012-12-07 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2012-12-07 Polymeropoulos Mihael Hristos President and CEO Grant or award · Restricted Stock Unit +50,000 50,000
2012-06-14 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2012-06-14 PIEN HOWARD H Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2012-06-14 MILANO VINCENT Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2012-06-14 Galson Steven K Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2012-06-14 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2012-06-14 COLA MICHAEL F Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion +7,500 12,015
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion +4,687 16,702
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Sale −4,760 $4.65 $22K 11,942

Page 35 of 36 · 717 trades